Therapeutic potential of octyl gallate isolated from fruits of Terminalia bellerica in streptozotocin-induced diabetic rats

Pharmaceutical Biology

Volumn 51, Issue 6, 2013, Pages 798-805

  Latha, R Cecily Rosemary ^a   Daisy, P ^a  

^a HOLY CROSS COLLEGE   (India)

Author keywords

Antihyperglycemic; Bioassay guided fractionation; Hypolipidemic; Insulin secretagogue; n octyl 3,4,5 trihydroxy benzoate

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; C PEPTIDE; CHOLESTEROL; CREATININE; DIMETHYL SULFOXIDE; ENZYME; GALLIC ACID; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INSULIN; INSULIN ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHANOL; OCTYL GALLIC ACID; PLANT EXTRACT; PROTEIN; TERMINALIA BELLERICA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG IDENTIFICATION; DRUG ISOLATION; ENZYME ACTIVITY; FRUIT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CALCIUM; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; GALLIC ACID; HYPOGLYCEMIC AGENTS; INDIA; INSULIN; INSULIN-SECRETING CELLS; MALE; MEDICINE, AYURVEDIC; RATS; RATS, WISTAR; SPECTRUM ANALYSIS; STREPTOZOCIN; TERMINALIA;

EID: 84877825830     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.766894     Document Type: Article

References (45)

1. Anand KK, Singh B, Saxena AK, et al. (1997). 3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia bellerica-bioassay guided activity. Pharmacol Res 36:315-21. (Pubitemid 27507590)
2. Anjana J, Monika B, Sangeeta S. (2007). Protective effect of Terminalia bellerica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J Ethnopharmacol 109:214-18.
3. Aurell M, Bjorck S. (1992). Determination of progressive renal disease in diabetes mellitus. Kidney Int 41:38-42.
4. Baginsky ES, Foa PP, Zak B. (1974). Glucose-6-phosphatase. In: Bergmeyer HU, Gawehn K, ed. Methods of Enzymatic Analysis, Vol. 2, 2nd ed. New York: Academic Press, 876-80.
5. Bjork S, Kapur A, King H, et al. (2003). Global policy: Aspects of diabetes in India. Health Policy 66:61-72. (Pubitemid 37123024)
6. Brandstrup N, Kirk JE, Bruni C. (1957). The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 12:166-71.
7. Choi JS, Yokozawa T, Oura H. (1991). Improvement of hyperglycemia and hyperlipidemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, pruning. Planta Med 57:208-11.
8. Cornblath M, Randle PJ, Parmeggiani A, Morgan HE. (1963). Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 238:1592-7.
9. Duncan BD. (1957). Multiple range tests for correlated and heteroscedastic means. Biometrics 13:164-76.
10. Genet S, Raosaheb KK, Najma ZB. (1999). Effects of vanadate, insulin and fenugreek (Trigonella foenum Graecum) on creatine kinase level in tissues of diabetic rat. Indian J Exp Biol 37:200-02. (Pubitemid 29103984)
11. Golden S, Wals PA, Okajima F, Katz J. (1979). Glycogen synthesis by hepatocytes from diabetic rats. Biochem J 182:727-34. (Pubitemid 10243677)
12. Howard BV, Abbott WG, Beltz WF, et al. (1987). Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36:870-7. (Pubitemid 17136045)
13. Ido Y, Vindigni A, Chang K, et al. (1997). Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563-6. (Pubitemid 27369004)
14. Jared D. (2011). Medicine: Diabetes in India. Nature 469:478-9.
15. Kasabri V, Flatt PR, Abdel-Wahab YHA. (2010). Terminalia bellerica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. Br J Nutr 103:212-17.
16. Kaur S, Arora S, Kaur K, Kumar S. (2002). The in vitro antimutagenic activity of Triphala, an Indian herbal drug. Food Chem Toxicol 40:527-34. (Pubitemid 34219279)
17. Kemp W. (1986). NMR in Chemistry: A Multinuclear Introduction. London: MacMillan Education.
18. Khan A, Gilani AH. (2008). Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect. J Food Drug Anal 16:6-14.
19. King H, Rewers M. (1991). Diabetes in adults is now a Third World problem. The WHO Ad Hoc Diabetes Reporting Group. Bull World Health Organ 69:643-8.
20. Latha RCR, Daisy P. (2010). Influence of Terminalia bellerica Roxb. fruit extracts on biochemical parameters in streptozotocin diabetic rats. Int J Pharmacol 6:89-96.
21. Latha RCR, Daisy P. (2011). Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chem Biol Interact 189:112-18.
22. Leloir LF, Goldemberg SH. (1960). Synthesis of glycogen from uridine diphosphate glucose in liver. J Biol Chem 235:919-23.
23. Lu Z, Nie G, Belton PS, et al. (2006). Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 48:263-74. (Pubitemid 43177148)
24. Mythili MD, Vyas R, Akila G, Gunasekaran S. (2004). Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 63:274-81. (Pubitemid 38702356)
25. Nakhoda A, Wong HA. (1979). The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia 35:1679-80. (Pubitemid 10157002)
26. Plummer TD. (1987). An Introduction to Practical Biochemistry. England: McGraw-Hill Book Company (UK) Limited.
27. Reinhold J. (1980). Determination of serum total protein, albumin and globulin fractions by the biuret method. In: Varley H, Gowenlock AH, Bell M, ed. Practical Clinical Biochemistry, Vol. I, 5th ed., London: William Heinemann Medical Book Limited, 545-7.
28. Sabu MC, Kuttan R. (2002). Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81:155-60. (Pubitemid 34628497)
29. Shaila HP, Udupa AL, Udupa SL. (1995). Preventive actions of Terminalia bellerica in experimentally induced atherosclerosis. Int J Cardiol 49:101-6.
30. Sharma SR, Dwivedi SK, Swarup D. (1997). Hypoglycemic, antihyperglycemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats. J Ethnopharmacol 58:39-44. (Pubitemid 27406185)
31. Shaw JE, Sicree RA, Zimmet PZ. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14.
32. Sicree R, Shaw J, Zimmet P. (2009). Diabetes and impaired glucose tolerance. In: Gan D, ed. Diabetes Atlas, 4th ed. Belgium: International Diabetes Federation, 1-105.
33. Silverstein RM, Bassler GC, Morrill TC. (1981). Spectroscopic Identification of Organic Compounds, 4th ed. New York: John-Wiley and Sons Inc.
34. Srivastava RD, Dwivedi S, Sreenivasan KK, Chandrashekhar CN. (1992). Cardiovascular effects of Terminalia species of plants. Indian Drugs 29:144-9.
35. Summanen J, Vuorela P, Rauha J, et al. (2001). Effects of simple aromatic compounds and flavonoids on Ca2+ fluxes in rat pituitary GH4C1 cells. Eur J Pharmacol 414:125-33. (Pubitemid 32181879)
36. Szkudelski T. (2001). The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol Res 50:537-46. (Pubitemid 34087272)
37. Tammela P, Vuorela P. (2004). Miniaturisation and validation of a cellbased assay for screening of Ca2+ channel modulators. J Biochem Biophys Methods 59:229-39. (Pubitemid 38681046)
38. Tan AW, Nuttall FQ. (1976). Regulation of synthase phosphatase and phosphorylase phosphatase in rat liver. Biochim Biophys Acta 445:118-30.
39. Tariq M, Hussain SJ, Asif M, Jahan M. (1977). Protective effect of fruit extracts of Emblica officinalis (Gaertn) and Terminalia bellerica (Roxb.) in experimental myocardial necrosis in rats. Indian J Exp Biol 15:485-6.
40. Thakur CP, Thakur B, Singh S, et al. (1988). The ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol 21:167-75.
41. Trinder P. (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24-7.
42. Valsaraj R, Pushpangadan P, Smitt UW, et al. (1997). New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica. J Nat Prod 60:739-42. (Pubitemid 27318429)
43. Wehrli FW, Marchand AP, Wehrli S. (1988). Interpretation of Carbon-13 NMR Spectra, 2nd ed. New York: Wiley.
44. Williams DH, Fleming I. (1989). Spectroscopic Methods in Organic Chemistry, 4th ed. London: McGraw-Hill Book Company.
45. Witters LA, Auruch J. (1978). Insulin regulation of hepatic glycogen synthetase and phosphorylase. Biochemistry 17:406-10. (Pubitemid 8277736)